Syndromology at the interface of evolving phenotypes, epimutations, and model systems

Nuria C. Bramswig,Dagmar Wieczorek

DOI: https://doi.org/10.1515/medgen-2024-2024

2024-06-07

Medizinische Genetik

Abstract:The field of syndromology spans a vast range of different and exciting research areas. Many famous clinical geneticists have laid the groundwork for today's landscape of syndromology. They described the clinical landscape of rare syndromes and started to unravel the underlying genetic causes. The advent of next generation sequencing technologies has led to the discovery of many novel disease-associated genes. This enabled clinical geneticists to increase the diagnostic yield and enlarge patient cohorts, broaden the phenotypic and genotypic spectrum of rare diseases and dig deeper into the underlying pathogenetic mechanisms. In this issue, we want to give an overview of this impressive development of syndromology by assembling a potpourri of different lines of research. We focus on the evolving phenotypes of rare diseases and their clinical management in adulthood, the booming field of epimutations, and the most commonly used model systems for exploration of pathogenetic mechanisms. Some research groups have started to focus on describing the evolving phenotypes of rare genetic diseases into adulthood. The article by Ariane Schmetz and colleagues gives an overview of these adult phenotypes and emphasizes the need of further studies to improve counselling of families with young children and adults with rare syndromes. They describe the phenotypes of four adult individuals with Costello syndrome illustrating the high variability of neurocognitive outcome and documenting recurrent carcinomata in some individuals. Dorothee Maliszewski-Makowka and Dagmar Wieczorek describe the developments in and missions of the so-called "MZEB" ("Medizinische Zentren für Erwachsene mit Behinderungen"), which were founded to ensure that adults with multiple disabilities receive medical care in an interdisciplinary and multi-professional setting. They summarize the efforts of the MZEB in the LVR clinic in Bedburg-Hau and the Institute of Human Genetics of the Heinrich-Heine University Düsseldorf to employ genetic testing in adults with mental disabilities and developmental and psychiatric disorders. The article written by Bernhard Horsthemke addresses the growing role of epigenetics in rare diseases by illustrating the classification of epimutations. Despite the large number of disease-associated chromatin modifier genes, for which he gives a comprehensive overview, the pathogenetic mechanisms remain to be elucidated. He concludes that the disease-relevant loci affected by the mutated chromatin modifier genes and their pathogenetic mechanisms are unknown and gives a critical outlook on the clinical application of newly developed epigenome editing tools. Different model systems are needed to gain insight into these and other pathogenetic mechanisms leading to syndromic diseases, to validate novel disease genes and variants of unknown significance and to assess potential therapeutic means for these rare diseases in a pre-clinical setting. The article by Anne Gregor and Christiane Zweier compiles the most commonly used models and outlines their application areas, as well as their advantages and limitations. We want to thank all authors for their valuable contributions and hope that the selected topics provide enticing insights into the recent developments in syndromology. 1 Centre of Medical Genetics, University and University Hospital Münster, Muenster, Germany 2 Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany 3 Center for Rare Diseases, Medical Faculty and University Hospital, Dusseldorf, Heinrich Heine University Düsseldorf, Germany PD Dr. med. Nuria C. Bramswig Univ.-Prof. Dr. med. Dagmar Wieczorek © 2024 the author(s), published by De Gruyter. This work is licensed under the Creative Commons Attribution 4.0 International License.

genetics & heredity

What problem does this paper attempt to address?

The paper primarily explores the latest advancements and challenges in the field of syndromology at the interface of evolving phenotypic, epigenetic variations, and model system research. The authors emphasize that with the development of next-generation sequencing technologies, clinical geneticists are better able to identify the genetic basis of rare diseases and delve deeper into their pathogenesis.

Specifically, the paper focuses on the following aspects:

1. **Phenotypic evolution of rare genetic diseases in adulthood**: Some research teams have begun to focus on the phenotypic changes in patients with rare genetic diseases as they enter adulthood. For example, Ariane Schmetz et al. outlined the phenotypic characteristics of adult patients and emphasized the importance of counseling for family members and adult patients. By describing the cases of 4 adult patients with Costello syndrome, they demonstrated the high variability in neurocognitive outcomes and the occurrence of cancer in some individuals.

2. **Role of epigenetic variation in rare diseases**: Bernhard Horsthemke's article discusses the importance of epigenetic variation in rare diseases and categorizes it. Although many disease-related chromatin modification genes are known, their exact pathogenesis remains to be elucidated. The author points out that it is currently unclear which specific gene loci are affected by these mutations and how they influence disease progression.

3. **Application of model systems**: Anne Gregor and Christiane Zweier summarized various model systems used to explore the pathogenesis of syndromic diseases and their application scope. These models help validate new disease-related genes, assess variants of unknown significance, and evaluate potential therapeutic approaches in a preclinical setting.

In summary, this paper aims to provide readers with an overview of recent developments in the field of syndromology by bringing together results from different research directions, with a particular focus on phenotypic changes in rare genetic diseases in adulthood, the role of epigenetic variation, and the application of model systems.